Stock 4568 DAIICHI SANKYO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Funds and ETFs Daiichi Sankyo Co., Ltd.

Equities

4568

JP3475350009

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-27 am EDT 		5-day change 1st Jan Change
5,627 JPY +3.36% Intraday chart for Daiichi Sankyo Co., Ltd. +1.74% +45.33%
May. 24 Jefferies Adjusts Daiichi Sankyo’s Price Target to 6,600 Yen From 5,600 Yen, Keeps at Buy MT
May. 20 AstraZeneca to build $1.5-bln cancer drug plant in Singapore RE

ETFs positioned on Daiichi Sankyo Co., Ltd.

Name Weight AuM 1st Jan change Investor Rating
DAY HAGAN/NED DAVIS RESEARCH SMART SECTOR INTERNATIONAL ETF - USD ETF Day Hagan/Ned Davis Research Smart Sector International ETF - USD
0.19% 32 M€ +7.50% -
VANECK MULTI-ASSET CONSERVATIVE ALLOCATION UCITS ETF - EUR ETF VanEck Multi-Asset Conservative Allocation UCITS ETF - EUR
0.18% 20 M€ +0.73% -
LYXOR NET ZERO 2050 S&P WORLD CLIMATE PAB (DR) UCITS ETF - ACC - USD ETF Lyxor Net Zero 2050 S&P World Climate PAB (DR) UCITS ETF - Acc - USD
0.17% 205 M€ -.--%
JPMORGAN ACTIVEBUILDERS INTERNATIONAL EQUITY ETF - USD ETF JPMorgan ActiveBuilders International Equity ETF - USD
0.16% 29 M€ +8.37% -
IMGP RBA RESPONSIBLE GLOBAL ALLOCATION ETF - USD ETF iMGP RBA Responsible Global Allocation ETF - USD
0.16% 7 M€ +0.11% -
AMUNDI MSCI WORLD CLIMATE PARIS ALIGNED PAB UCITS ETF DR (C) - USD ETF AMUNDI MSCI WORLD CLIMATE PARIS ALIGNED PAB UCITS ETF DR (C) - USD
0.13% 284 M€ -.--%
AMUNDI MSCI WORLD CLIMATE TRANSITION CTB UCITS ETF DR (C) - EUR ETF AMUNDI MSCI WORLD CLIMATE TRANSITION CTB UCITS ETF DR (C) - EUR
0.13% 786 M€ -.--%
AMUNDI MSCI WORLD CLIMATE TRANSITION CTB UCITS ETF DR (C) - USD ETF AMUNDI MSCI WORLD CLIMATE TRANSITION CTB UCITS ETF DR (C) - USD
0.13% 23 M€ -.--% -
LYXOR MSCI WORLD CLIMATE CHANGE (DR) UCITS ETF - ACC - USD ETF Lyxor MSCI World Climate Change (DR) UCITS ETF - Acc - USD
0.13% 206 M€ -.--%
RBC QUANT EAFE EQUITY LEADERS ETF - USD ETF RBC Quant EAFE Equity Leaders ETF - USD
0.11% 2 M€ +9.19% -
RBC QUANT EAFE EQUITY LEADERS (CAD HEDGED) ETF - HEDGED CAD ETF RBC Quant EAFE Equity Leaders (CAD Hedged) ETF - HEDGED CAD
0.11% 2 M€ -.--% -
LEVERAGE SHARES 3X LONG TOTAL WORLD ETP SECURITIES - USD ETF Leverage Shares 3x Long Total World ETP Securities - USD
0.11% 0 M€ 0.00% -
AMUNDI INDEX MSCI WORLD UCITS ETF - EUR ETF AMUNDI INDEX MSCI WORLD UCITS ETF - EUR
0.10% 1,166 M€ +0.26% -
AMUNDI INDEX MSCI WORLD UCITS ETF DR (D) - EUR ETF AMUNDI INDEX MSCI WORLD UCITS ETF DR (D) - EUR
0.10% 607 M€ +0.05% -
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF ACC - EUR ETF Vanguard LifeStrategy 80% Equity UCITS ETF Acc - EUR
0.09% 391 M€ +9.28% -
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 80% Equity UCITS ETF - Distributing - EUR
0.08% 34 M€ +9.10% -
RAREVIEW SYSTEMATIC EQUITY ETF - USD ETF Rareview Systematic Equity ETF - USD
0.07% 45 M€ 0.00% -
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD ETF Unlimited HFND Multi-Strategy Return Tracker ETF - USD
0.06% 34 M€ +4.20% -
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 60% Equity UCITS ETF - Distributing - EUR
0.06% 39 M€ +5.88% -
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - ACC - EUR ETF Vanguard LifeStrategy 60% Equity UCITS ETF - Acc - EUR
0.06% 306 M€ +6.14% -
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF ACC - EUR ETF Vanguard LifeStrategy 40% Equity UCITS ETF Acc - EUR
0.05% 105 M€ +3.78% -
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 40% Equity UCITS ETF - Distributing - EUR
0.04% 17 M€ +3.03% -
VANGUARD LIFESTRATEGY 20% EQUITY UCITS ETF ACC - EUR ETF Vanguard LifeStrategy 20% Equity UCITS ETF Acc - EUR
0.02% 54 M€ +0.82% -
ADAPTIVE GROWTH OPPORTUNITIES ETF - USD ETF Adaptive Growth Opportunities ETF - USD
0.02% 234 M€ +9.05% -
123

Company Profile

Daiichi Sankyo Company specializes in developing, manufacturing and marketing pharmaceutical products. Net sales break down by activity as follows: - sale of medicines (99.8%): prescription medicines (92.8% of net sales) and OTC medicines (7.2%) primarily for the treatment of thrombotic disorders, tumors, diabetes and rheumatoid arthritis; - other (0.2%): primarily real estate activities. Net sales are distributed geographically as follows: Japan (64.1%), North America (17.2%), Europe (9.7%) and other (9%).
Sector
Pharmaceuticals
Calendar
2024-06-01 - American Society of Clinical Oncology Meeting - Abstract No TPS3165
Related indices
Nikkei 225
More about the company

Income Statement Evolution

More financial data

Ratings for Daiichi Sankyo Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
5,444 JPY
Average target price
5,960 JPY
Spread / Average Target
+9.48%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
DAIICHI SANKYO CO., LTD. Stock Daiichi Sankyo Co., Ltd.
+45.33% 66.5B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+38.51% 727B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.14% 599B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.23% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.78% 328B
ABBVIE INC. Stock AbbVie Inc.
+1.35% 277B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.00% 243B
NOVARTIS AG Stock Novartis AG
+8.07% 205B
ROCHE HOLDING AG Stock Roche Holding AG
-5.85% 203B
AMGEN INC. Stock Amgen Inc.
+6.19% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4568 Stock
  4. Funds and ETFs Daiichi Sankyo Co., Ltd.